COVID-19 DNA Vaccine Halt Another Blow To AnGes

R&D Starts On Intranasal Vaccine

 
• By Lisa Takagi
  
Following the cancellation of DNA vaccine for COVID-19, Anges will start a new joint research for intranasal alternative
Following the cancellation of a DNA vaccine for COVID-19, Anges will start joint research for an intranasal alternative • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia